Comparison of efficacy and safety between third‐dose triple and third‐dose dual antihypertensive combination therapies in patients with hypertension

We compared the efficacy and safety of third‐standard‐dose triple and third‐standard‐dose dual antihypertensive combination therapies in patients with mild to moderate hypertension. This was a phase II multicenter, randomized, double‐blind, parallel‐group trial. After a 4‐week placebo run‐in period,...

Descripción completa

Detalles Bibliográficos
Autores principales: Sung, Ki‐Chul, Hong, Soon Jun, Rhee, Moo‐Yong, Jeong, Myung‐Ho, Kim, Dae‐Hee, Lim, Sang‐Wook, Park, Kyungil, Lee, Jin Bae, Kim, Seok‐Yeon, Cho, Jin‐Man, Cho, Goo‐Yeong, Heo, Jung‐Ho, Kim, Sang‐Hyun, Lee, Hae‐Young, Kim, Weon, Cho, Deok‐Kyu, Park, Sungha, Shin, Jinho, Pyun, Wook‐Bum, Kwon, Kihwan, Rha, Seung‐Woon, Jung, Jin‐A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Combination Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184484/
https://www.ncbi.nlm.nih.gov/pubmed/37095689
http://dx.doi.org/10.1111/jch.14656

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184484/
https://www.ncbi.nlm.nih.gov/pubmed/37095689
http://dx.doi.org/10.1111/jch.14656

Ejemplares similares